SCHEMBL4510288

SCHEMBL4510288

COC(=O)c1cccc(COc2cc(Cl)ccc2Cl)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 12/20 0.74
SMN1; SMN2 Q16637 7/20 0.68
THRB P10828 1/20 0.68
NPC1 O15118 6/20 0.67
RAB9A P51151 6/20 0.67
ALDH1A1 P00352 4/20 0.67
TP53 P04637 2/20 0.67
HPGD P15428 4/20 0.66
MAPT P10636 2/20 0.66
TDP1 Q9NUW8 1/20 0.66
GAA P10253 1/20 0.64
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.55
MITF O75030 1/20 0.55
XBP1 P17861 1/20 0.55
NFKB1 P19838 1/20 0.55
NFKB2 Q00653 1/20 0.55
KMT2A Q03164 1/20 0.55
RELA Q04206 1/20 0.55
HTT P42858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22480888 0.90 MRGPRX4 (0.74) MRGPRX4SMN1; SMN2THRBNPC1RAB9A
SCHEMBL26162589 0.86 MRGPRX4 (0.77) MRGPRX4SMN1; SMN2THRB
SCHEMBL4502608 0.85 MRGPRX4 (1.00) MRGPRX4SMN1; SMN2THRBNPC1RAB9A
SCHEMBL15235340 0.85 MRGPRX4 (0.70) MRGPRX4SMN1; SMN2THRBNPC1RAB9A
SCHEMBL559537 0.83 NOTUM (0.58) MRGPRX4SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL15227963 0.82 MRGPRX4 (0.66) MRGPRX4SMN1; SMN2THRBNPC1RAB9A
SCHEMBL22469980 0.82 MRGPRX4 (1.00) MRGPRX4
SCHEMBL692883 0.82 MRGPRX4 (0.66) MRGPRX4SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL6438620 0.81 MRGPRX4 (0.58) MRGPRX4SMN1; SMN2THRBNPC1RAB9A
SCHEMBL9368856 0.81 MRGPRX4 (0.74) MRGPRX4SMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS MRGPRX4 1550/4885SMN1; SMN2 2075/4885THRB 2175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.